Recombinant Human BMP-13

Recombinant Human BMP-13

Product No.: B423

[product_table name="All Top" skus="B423"]

- -
- -
Alternate Names
GDF-6, Cartilage-Derived Morphogenetic Protein 2 [CDMP-2]
Product Type
Recombinant Protein
Expression Host
E. coli Cells
Species
Mouse

- -
- -
Select Product Size
- -
- -

Background

Bone Morphogenetic Protein-13 (BMP-13) is a member of the transforming growth factor beta (TGF-beta) superfamily of growth factors that may regulate patterning of the ectoderm by interacting with bone morphogenetic proteins and control eye development. The biological actions of BMP-13 remain poorly understood. Expression of BMP-13 is predominantly seen in hypertrophic chondrocytes in regions of endochondral bone formation during development. BMP-13 in post natal articular cartilage suggests that this protein may function in an autocrine/paracrine way to regulate the growth and maintenance of articular cartilage. In addition to this BMP-13 has been shown to induce neotendon/neoligament formation when injected on a collagen carrier subcutaneously or intramuscularly. This indicates that BMP-13 may have therapeutic value for tendon or ligament healing following injury.

At the amino acid sequence level, human and mouse GDF-6 are 99% identical. GDF-6 response is mediated by the formation of hetero-oligomeric complexes of type I (BMPR-IB) and type II (BMPR-II or Activin R-II) sereine/threonine kinase receptors, and the activation of Smad proteins.

Protein Details

Purity
>97% by SDS-PAGE and analyzed by silver stain.
Endotoxin Level
<0.1 EU/µg as determined by the LAL method
Biological Activity
The ED<sub>50</sub> was determined by its ability to induce alkaline phosphatase production by ATDC-5 chondrogenic cells<sup>1</sup> in the range of 2.0-3.0 µg/ml.
Protein Accession No.
P43028
Amino Acid Sequence
tafasr hgkrhgkksr lrcsrkplhv nfkelgwddw iiapleyeay hcegvcdfpl rshleptnha iiqtlmnsmd pgstppsccv ptkltpisil yidagnnvvy kqyedmvves cgcr
N-terminal Sequence Analysis
Thr335
State of Matter
Solution
Predicted Molecular Mass
The predicted molecular weight of Recombinant Human BMP-13 is 13.7 kDa.
Predicted Molecular Mass
13.7
Formulation
This recombinant protein was 0.2 µm filtered and is supplied in a solution of 35% acetonitrile (CH3CN) and 0.1% trifluoroacetic acid (TFA).
Storage and Stability
Working aliquots of this recombinant protein solution are stable for up to twelve months at -20°C to -70°C in a manual defrost freezer. Upon thawing, in the presence of a carrier protein, this recombinant protein can be stored at 2° - 8°C for one month without detectable loss of activity. For long-term storage, aliquot and freeze at -20°C to -70°C in a manual defrost freezer. Avoid repeated freeze thaw cycles.
Country of Origin
USA
Shipping
Dry Ice
NCBI Gene Bank

References & Citations

1. Nakamura, K. et al. (1999) Exp. Cell Res. 250:351
IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
- -
- -
Prod No.
Description
B423
Products are for research use only. Not for use in diagnostic or therapeutic procedures.